BPR-20877-46317
2 vaccinations
4 coded responses
15 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Registered in v-safe
- 2021-03-26
-
2021-04-01
Dose 2 — Pfizer-BioNTech
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Injection site haemorrhage — Feeling: Good · Site: PainFree text: It bled again at the injection site but not like when I got the first. With dose #1, the injection site bled profusely and a got a large bruise appox 3" in diameter. No bruising with #2.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-04
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-08
Health check-in — day 7, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-15
- 2021-04-22
-
2021-04-29
Survey response — day 28, dose 2MedDRA: Pruritus — Feeling: GoodFree text: Increase in itching but no rash like previously.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
-
2021-05-14
Survey response — day 42, dose 2MedDRA: Pruritus — Feeling: GoodFree text: Some intense localized itching, but not at the injection site, and no where near as bad as when I received the 2nd dose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-01
Survey response — 3 months, dose 2MedDRA: Angina pectoris, Cough, Fatigue, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Starting Tuesday, June 1st, I developed severe coughing, severe sore throat, heart pain, extreme fatigue. At day 4, I went for a covid test. It came back negative. The cough persists today, but not severe.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): It bled again at the injection site but not like when I got the first. With dose #1, the injection site bled profusely and a got a large bruise appox 3" in diameter. No bruising with #2.
Release 8 — day 28, dose 2
Symptoms: Increase in itching but no rash like previously.
Release 8 — day 42, dose 2
Symptoms: Some intense localized itching, but not at the injection site, and no where near as bad as when I received the 2nd dose.
Release 9 — 3 months, dose 2
Symptoms: Starting Tuesday, June 1st, I developed severe coughing, severe sore throat, heart pain, extreme fatigue. At day 4, I went for a covid test. It came back negative. The cough persists today, but not severe.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angina pectoris | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SRO | Injection site haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release